RegIIIβ is, at first, produced by epithelial cells through IL-23 receptor signaling, and the epithelial-derived RegIIIβ then recruits IL-22-producing neutrophils that contribute for the improvement of colitis [48]. The gene discussed is IL22; the disease is colitis.